GCL
AEON icon

Glazer Capital LLC’s AEON Biopharma AEON Stock Holding History

Glazer Capital LLC’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-822
Closed -$613K – 169
2023
Q2 		$613K Sell
822
-2,269
-73% -$1.59M 0.04% 157
2023
Q1 		$2.26M Sell
3,091
-116
-4% -$84.2K 0.12% 156
2022
Q4 		$2.32M Buy
3,207
+71
+2% +$50.9K 0.06% 218
2022
Q3 		$2.22M Buy
3,136
+3
+0.1% +$2.13K 0.04% 307
2022
Q2 		$2.21M Buy
3,133
+169
+6% +$119K 0.06% 318
2022
Q1 		$2.09M Buy
2,964
+2,928
+8,133% +$2.05M 0.06% 250
2021
Q4 		$25K Hold
36
– – ﹤0.01% 769
2021
Q3 		$25K Sell
36
-2
-5% -$1.4K ﹤0.01% 855
2021
Q2 		$26K Buy
+38
New +$26.6K ﹤0.01% 883

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Glazer Capital LLC's AEON Position: Q3 2023 in Review

Glazer Capital LLC sold out of AEON Biopharma (AEON) in Q3 2023, closing a stake of 822 shares — an estimated $613K sold.

Glazer Capital LLC first reported a position in AEON in Q2 2021 and held it in 9 quarters. The position peaked at $2.32M in Q4 2022. 15 funds tracked by Wall St. Rank hold AEON as of Q3 2023.

  • Glazer Capital LLC reported no remaining AEON Biopharma position as of Q3 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 822 AEON Biopharma shares in Q3 2023, an estimated $613K.
  • Glazer Capital LLC first reported a position in AEON Biopharma in Q2 2021 and held it in 9 quarters.
  • Glazer Capital LLC's AEON Biopharma position peaked at $2.32M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2023.

Based on Glazer Capital LLC's 13F filing for Q3 2023, filed 14 Nov 2023.